#22974 Vibegron Shows Meaningful Changes in Clinical Endpoints in Patients with Overactive Bladd...

#33 Once-Daily Vibegron 75 mg for Overactive Bladder: Double-Blind 52-Week Results From an Exten...Подробнее

#440 Once-Daily Vibegron 75 mg Improves Quality-of-Life and Incontinence Efficacy Endpoints in P...Подробнее

Efficacy of vibegron, a novel β3‐adrenoreceptor agonist, on severe UUI related to overactive bladderПодробнее

Ureter jetting urine into the bladderПодробнее

Overactive bladder syndrome: new treatment option (vibegron)Подробнее

181 Once Daily Vibegron 75 mg Demonstrates Statistically Significant Benefits on Key Secondary EnПодробнее

#22969 Vibegron for the Treatment of Patients With Dry Overactive Bladder: A Subgroup Analysis F...Подробнее

#22989 Effects of Vibegron on Ambulatory Blood Pressure in Patients With Overactive Bladder: Res...Подробнее

180 Efficacy of vibegron, a novel selective B3 adrenoreceptor agonist, on urgency urinary incontiПодробнее

13 Drugs for Overactive Bladder - Vibegron, Darifenacin, DuloxetineПодробнее

Dr. Ashley Tapscott Discusses an Effective Treatment for Overactive BladderПодробнее

Conservative Management of Overactive BladderПодробнее

Integrating patients' experiences in bladder cancer therapeutic decisions: challenges and solutionsПодробнее

Overactive bladder is a common condition with many treatments.Подробнее

Ask a Specialist: Bladder HealthПодробнее

#460 Efficacy of vibegron, a novel β3-adrenoreceptor agonist on storage and voiding dysfunction ...Подробнее

Dangers of Holding your UrineПодробнее

Ongoing clinical trials in bladder cancerПодробнее